Shandong Buchang Pharmaceuticals Co., Ltd. (SHA: 603858)

Shandong Buchang Pharmaceuticals Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 5, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	15,770	18,814	23,238	23,326	25,516	22,807
Market Cap Growth	-27.12%	-19.04%	-0.38%	-8.58%	11.88%	1.78%
Enterprise Value	17,866	21,044	23,744	25,505	27,096	23,121
Last Close Price	14.61	16.87	19.83	19.52	20.79	17.63
PE Ratio	-	58.50	-14.34	16.75	12.36	10.11
PS Ratio	1.37	1.42	1.55	1.48	1.59	1.60
PB Ratio	1.40	1.65	1.89	1.61	1.85	1.65
P/FCF Ratio	-43.55	-25.93	10.50	26.30	17.94	11.64
P/OCF Ratio	492.02	-96.18	8.43	17.66	13.03	8.70
EV/Sales Ratio	1.52	1.59	1.59	1.62	1.69	1.62
EV/EBITDA Ratio	18.80	14.55	10.53	11.42	9.99	8.69
EV/EBIT Ratio	30.20	20.32	13.37	14.65	11.85	10.16
EV/FCF Ratio	-46.89	-29.01	10.73	28.76	19.05	11.80
Debt / Equity Ratio	0.36	0.29	0.27	0.24	0.25	0.20
Debt / EBITDA Ratio	4.20	2.25	1.45	1.57	1.27	1.02
Debt / FCF Ratio	-10.48	-4.54	1.49	3.99	2.43	1.39
Asset Turnover	0.54	0.62	0.65	0.67	0.73	0.69
Inventory Turnover	1.03	0.99	1.12	1.25	1.59	1.44
Quick Ratio	0.48	0.45	0.71	0.57	0.62	0.77
Current Ratio	1.28	1.21	1.29	1.17	1.02	1.15
Return on Equity (ROE)	-3.06%	1.28%	-11.91%	8.74%	13.36%	14.20%
Return on Assets (ROA)	1.71%	3.02%	4.83%	4.64%	6.49%	6.90%
Return on Capital (ROIC)	2.43%	4.28%	6.61%	6.17%	8.46%	8.72%
Earnings Yield	-1.22%	1.70%	-6.58%	5.53%	7.29%	8.53%
FCF Yield	-2.42%	-3.86%	9.52%	3.80%	5.57%	8.59%
Dividend Yield	0.86%	0.75%	4.84%	1.84%	2.53%	9.15%
Payout Ratio	0.00%	374.41%	-	57.88%	133.71%	47.31%
Buyback Yield / Dilution	0.42%	0.00%	0.01%	-0.00%	0.87%	2.26%
Total Shareholder Return	1.28%	0.75%	4.85%	1.84%	3.40%	11.41%

Source: S&P Capital IQ. Standard template. Financial Sources.